A bone marrow transplant is a process to replace unhealthy bone marrow with the healthy one – treating life-threatening blood cancers like leukemia, lymphoma, myeloma, certain blood, immune system and metabolic disorders – sickle cell anaemia, thalassaemia, severe combined immunodeficiency (SCID) and Hurler syndrome and bone marrow failure like aplastic anemia, etc.
In current days, Bone marrow transplantation is the only curative therapy for blood diseases. However, having a stem cell transplant can be an intensive and challenging experience due to the complicated procedures associated with significant risks.
Extensive research is in progress for the development of latest advancements in benefit to the mankind. According to the reports published in the Journal Nature Biotechnology, Scientists from Harvard Stem Cell Institute (HSCI) have taken the initiation towards developing a treatment that would make bone marrow blood stem cell transplantation safer.
Scientists from the University of Southern California say that they have found clues about how the dose of transplanted bone marrow might affect patients undergoing bone marrow transplantation.
If the current developments and approach works in humans, it would really change the world of transplantation or regenerative medicine.